The skilled trial lawyers at Morgan, Lewis & Bockius LLP act for both patent holders and accused infringers at all levels of the US Court system, standing out in particular for their experience litigating Section 337 proceedings at the International Trade Commission. Chicago-based litigator Michael Abernathy has extensive experience in the pharmaceutical and tech sectors, having litigated Hatch-Waxman cases, Section 337 investigations, and importation disputes in the Court of International Trade. Also in Chicago, Krista Vink Venegas is experienced in intellectual property disputes in the life sciences and medtech sectors, and Jason White acts in a wide range of contentious IP matters. In San Francisco, Michael Lyons focuses on patent, copyright, trade dress, trade secret and other tech-focused litigation, and Brent Hawkins is an experienced IP and commercial disputes litigator. William Peterson in Houston, who specializes in appellate representation in matters such as patent infringement, is another key practitioner, as is Wilmington lawyer John Gorman, who handles commercial and IT disputes in the tech sector.
Key clients
- Zebra Technologies Corporation
- Nippon Shinyaku Co. Ltd.
- Takeda Pharmaceuticals, U.S.A., Inc.
- Salix Pharmaceutical, Ltd.
- Bausch Health Ireland, Ltd.
- Alphasigma S.p.a.
- HPE
- One World Technologies
- Techtronic Power Tools Technology Ltd.
- Medacta USA
- Medacta International
- NetScout Systems, Inc.
- ASSA ABLOY entities
- Xencor
- Haas Automation Inc.
- Canon U.S.A. Inc.
- Canon Solutions America, Inc.
- Visteon Corporation
- Nationwide Children’s Hospital
Work highlights
- Assisted Haas Automation Inc. in securing a Federal Circuit affirmance of its win in an IPR before the PTAB for a patent concurrently being asserted by Olati LLC against Haas in the US District Court for the Central District of California.
- Represented Takeda Pharmaceuticals in a lawsuit brought by drug wholesalers alleging a conspiracy among defendants to restrain trade and monopolize an alleged market for gout drug Colcrys® and its AB-rated generics.
- Assisted Nippon Shinyaku with securing a preliminary injunction ordering Sarepta Therapeutics Inc. to withdraw its previously filed IPR petitions related to Nippon Shinyaku’s novel therapy to treat Duchenne muscular dystrophy.
Practice head
The lawyer(s) leading their teams.
Michael Abernathy, John Gorman, Michael Lyons, Krista Vink Venegas, Jason White